Philips released the latest set of safety test results on Tuesday, covering all CPAP and BiPAP sleep therapy machines included in the recall—which together make up about 95% of all of the recalled ...
The US Food and Drug Administration issued a Class I recall Friday, the most serious type of recall, for certain Philips Respironics DreamStation1 CPAP machines. A Class I recall means the FDA has ...
Drugwatch has provided people injured by harmful drugs and devices with reliable answers and experienced legal help since 2009. Brought to you by The Wilson Firm LLP, we've pursued justice for more ...
Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.
Certain Philips Respironics DreamStation breathing devices, commonly used for treating sleep apnea, may deliver the incorrect prescription or no therapy at all, the FDA warned in a recall announcement ...
On April 7, 2023, the FDA identified a Class I recall on the Philips Respironics CPAP and BiPAP machines due to inaccurate or insufficient therapy. The devices, intended for treating sleep apnea, had ...
Philips' latest recall spans 1,233 DreamStation sleep therapy devices, used both in hospital settings and in a patient’s own home. (Philips) In a classic “two steps forward, one step back” situation, ...
On September 6, 2022, the FDA shared that Philips recalled specific Philips Respironics masks for BiPAP and CPAP machines. The FDA’s news release shares that these devices have magnets in them, which ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results